Leiomyoma
78
5
5
47
Key Insights
Highlights
Success Rate
82% trial completion
Published Results
14 trials with published results (18%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
12.8%
10 terminated out of 78 trials
82.5%
-4.1% vs benchmark
26%
20 trials in Phase 3/4
30%
14 of 47 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 47 completed trials
Clinical Trials (78)
Prescription of Letrozole for Uterine Myoma
Dexamethasone for Post Uterine Artery Embolization Pain
Mechanistic Characterization of Uterine Pain
Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)
Fertility After Myomectomy Versus Uterine Artery Embolization for Symptomatic Uterine Fibroids
Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL)
An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
CEH-EUS for Differentiating GISTs and Leiomyomas: A Multicenter Prospective Self-Controlled Study
Multicenter Observational Study of Multimodal AI for Upper GI Mesenchymal Tumor Diagnosis
Effects of Simvastatin on Uterine Leiomyoma Size
Power Morcellation Systems for Laparoscopic Hysterectomy and Myomectomy
Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914
Single Arm Study Using the Symphony -- MRI Guided Focused Ultrasound System for the Treatment of Leiomyomas
Combined Vaginal Misoprostol and Perivascular Vasopressin
Concordance Between Sonography Amd MRI for Presurgical Diagnosis of Uterine Mesenchymal Malignant Tumors
Hemostatic Effect of Intrauterine Instillation of Oxytocin in Hysteroscopic Myomectomy
Detective Flow Imaging Endoscopic Ultrasonography in Subepithelial Lesions
Trial of Mifepristone for Fibroids
Evaluation of Women With Endocrine and Reproductive-Related Conditions
Characterisation of Uterine Fibroid Tissue Stiffness